Acute Neuroimmune Effects of Alcohol Using Free Water Imaging
NCT ID: NCT03370783
Last Updated: 2022-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2017-03-31
2017-09-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Effects of Alcohol on Brain Chemistry
NCT01492933
Reactions to E-cigs and Alcohol
NCT03449017
Neuroendocrine Response to Oral Alcohol Administration
NCT03165942
Effect of Nutritional Ketosis on Alcohol Metabolism
NCT06065657
Dehydration Cognition
NCT05916183
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ethanol
Moderate alcohol consumption
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak and read English at least at 8th grade level
* Moderate self-reported alcohol use in the past year
* Body mass index in normal to overweight range
* Right-handed
Exclusion Criteria
* Currently seeking alcohol or drug treatment
* Chronic disease requiring use of medication
* Recent antibiotic or probiotic use
* Chronic daily use of NSAIDs
* Chronic GI disorder
* Use of illicit drugs
* Major psychiatric disorder or suicidality
* Fainting, weakness, infection, excessive bruising, or distress resulting from standard blood draw
* Safety contraindication for MRI scan
* Inability to abstain from use of tobacco products prior to or during study
* Inability to abstain from use of cannabis prior to or during study
* Pregnant, nursing, or may become pregnant
21 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of General Medical Sciences (NIGMS)
NIH
Brown University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mollie Monnig
Assistant Professor of Behavioral and Social Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brown University
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1608001583
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.